Nav: Home

ESIB -- European Summit of Industrial Biotechnology 2016

May 23, 2016

Participants at this year's European Summit of Industrial Biotechnology (ESIB) are going to focus on "design" in biotechnology - at an event that not only covers science but also deals with industrial needs and hopes, economic challenges, funding resources or political aspirations. The ESIB will take place in the historic city of Graz in the heart of Europe from November 14th to 16th, 2016.

Hundreds of scientific conferences and dozens of partnering events and fairs are held per year. Most of them provide great platforms for scientific presentations and exchange of expertise. However, the European Summit of Industrial Biotechnology (ESIB) goes one step further. It has not been designed to be another conference or another partnering event among many others. The ESIB is a platform for industrial biotechnology in multiple contexts. It has been designed to encourage all protagonists of industrial biotechnology to think outside the box and in new and comprehensive dimensions.

This year's vision is about design - this guiding thread of the 2½ days event unites major contributors to international industrial biotechnology under one roof to learn from celebrated experts, executives, and entrepreneurs, to get new inputs from politics and funding agencies and finally to develop profitable ideas with prospective partners.

We invite you to seize the opportunity to discuss vital questions and encouraging topics and to be on top of new insights and trends at the ESIB 2016 from November 14-16 in Graz, Austria. This year's topics will cover trends in biotech science and industry, cascade design and metabolic engineering, designing nature (e.g. proteins for competitive bioprocesses), in-silico approaches in modern industrial biotechnology and much more.

The European Summit of Industrial Biotechnology 2016 is organized by acib, the Austrian Centre of Industrial Biotechnology. Find more information about the ESIB 2016 at http://www.esib.at

About acib

The Austrian Centre of Industrial Biotechnology (acib) is an international research center for industrial biotechnology with locations in Vienna, Graz, Innsbruck, Linz, Tulln, Hamburg, Heidelberg and Bielefeld (DE), Pavia (IT), Ljubljana (SI), Barcelona (ES) and Rzeszow (PL). Additionally, acib is a scientific and industrial network of 130+ partners, including 3M, G.L. Pharma, Boehringer Ingelheim, DSM, Baxalta, Lon-za, Sandoz, VTU Technology, etc.

At acib, 200+ employees work on more than 70 research projects with the final goal to replace conventional industrial processes and products by more environmentally friendly and more economical approaches. More information about acib's research can be found in acib's "Biotech Stories": goo.gl/3GBEr9

acib is owned by the University of Natural Resources and Life Sciences, Graz University of Technology, the Universities of Innsbruck and Graz and the Styrian Joanneum Research. acib is financed by industrial and public contributions. The latter come from the Austrian Research Promotion Agency of the Republic of Austria (FFG), Standortagentur Tirol, Styrian Business Promotion Agency (SFG), the province of Lower Austria and the Vienna Business Agency.

http://www.acib.at
-end-


Austrian Research Centre of Industrial Biotechnology (ACIB)

Related Biotechnology Articles:

Biotechnology to the rescue of Brussels sprouts
An international team has identified the genes that make these plants resistant to the pathogen that attacks crops belonging to the cabbage family all over the world.
UM professor co-authors report on the use of biotechnology in forests
University of Montana Professor Diana Six is one of 12 authors of a new report that addresses the potential for biotechnology to provide solutions for protecting forest trees from insect and pathogen outbreaks, which are increasing because of climate change and expanded global trade.
Faster genome evolution methods to transform yeast for industrial biotechnology
A research team led by Prof. DAI Junbiao at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences, in collaboration with Prof.
New innovations in cell-free biotechnology
Professor Michael Jewett's new platform to conduct cell-free protein synthesis could lead to improved quality of manufactured protein therapeutics and biomaterials.
Silk 'micrococoons' could be used in biotechnology and medicine
Microscopic versions of the cocoons spun by silkworms have been manufactured by a team of researchers.
More Biotechnology News and Biotechnology Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...